Related Experiment Videos
Therapy for gonococcal infections: options in 1989.
1Division of Sexually Transmitted Diseases, Centers for Disease Control, Atlanta, Georgia 30333.
Reviews of Infectious Diseases
|July 1, 1990
Summary
Ceftriaxone is the recommended treatment for Neisseria gonorrhoeae infections, offering a simple and effective single intramuscular dose. Alternative antibiotics exist, but doxycycline is advised for potential chlamydial coinfections.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Antibiotic resistance complicates treatment choices for Neisseria gonorrhoeae.
- Varying antibiotic efficacy across different infection sites presents a challenge.
Purpose of the Study:
- To evaluate the efficacy of Ceftriaxone for Neisseria gonorrhoeae infections.
- To identify alternative therapeutic options and address coinfections.
Main Methods:
- Review of current therapeutic guidelines and clinical data.
- Analysis of antibiotic resistance patterns and site-specific efficacy.
Main Results:
- Ceftriaxone (250 mg IM) is a well-tolerated, effective single-dose treatment for uncomplicated N. gonorrhoeae at all sites.
- Alternative single-dose regimens include oral ciprofloxacin, norfloxacin, cefuroxime axetil, and IM spectinomycin, ceftizoxime, cefotaxime.
- Doxycycline (100 mg BID for 7 days) is recommended for presumptive chlamydial coinfection.
Conclusions:
- Ceftriaxone is a primary choice for gonorrhea treatment due to its efficacy and tolerability.
- Tetracyclines are not recommended as monotherapy due to widespread resistance.
- Co-treatment for chlamydial coinfection is essential.